Gregory M. Vercellotti
University of Debrecen
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Gregory M. Vercellotti.
Journal of Clinical Investigation | 1985
Gregory M. Vercellotti; B S van Asbeck; H. S. Jacob
Human neutrophils (PMN), when stimulated with such chemotaxins as phorbol myristate acetate (PMA), destroy erythrocytes and other targets. Cytotoxicity depends on PMN-generated reactive oxygen metabolites, yet the exact toxic specie and its mode of production is a matter of some dispute. Using 51Cr-labeled erythrocytes as targets, we compared various reactive-O2 generating systems for their abilities to lyse erythrocytes as well as to oxidize hemoglobin to methemoglobin. PMA-activated PMNs or xanthine oxidase plus acetaldehyde were added to target erythrocytes in amounts that provided similar levels of superoxide. PMNs lysed 68.3 +/- 2.9% (SEM) of targets, whereas the xanthine oxidase system was virtually impotent (2.3 +/- 0.8%). In contrast, methemoglobin formation by xanthine oxidase plus acetaldehyde was significantly greater than that caused by stimulated PMNs (P less than 0.001). A similar dichotomy was noted with added reagent H2O2 or the H2O2-generating system, glucose plus glucose oxidase; neither of these caused 51Cr release, but induced 10-70% methemoglobin formation. Thus, although O2- and H2O2 can cross the erythrocyte membrane and rapidly oxidize hemoglobin, they do so evidently without damaging the cell membrane. That a granule constituent of PMNs is required to promote target cell lysis was suggested by the fact that agranular PMN cytoplasts (neutroplasts), although added to generate equal amounts of O2- as intact PMNs, were significantly less lytic to target erythrocytes (P less than 0.01). Iron was shown to be directly involved in lytic efficiency by supplementation studies with 2 microM iron citrate; such supplementation increased PMN cytotoxicity by approximately 30%, but had much less effect on erythrocyte lysis by neutroplasts (approximately 3% increase), and no effect on lysis in the enzymatic oxygen radical-generating systems. These results suggest a critical role for an iron-liganding moiety that is abundantly present in PMN, marginally so in neutroplasts, and not at all in purified enzymatic systems--a moiety that we presume catalyzes very toxic O2 specie generation in the vicinity of juxtaposed erythrocyte targets. The obvious candidate is lactoferrin (LF), and indeed, antilactoferrin IgG, but not nonspecific IgG, reduced PMN cytotoxicity by greater than 85%. Re-adding 10(-8) M pure LF to neutroplasts increased their ability to promote hemolysis by 48.4 +/- 0.9%--to a level near that of intact PMNs. We conclude that O-2 and H2O2 are not sufficient to mediate target cell lysis, but require iron bound to LF, which, in turn, probably generates and focuses toxic O2 radicals, such as OH, to target membrane sites.
FEBS Letters | 2000
Jun Wang; Paul H. Marker; John D. Belcher; David E.L. Wilcken; Linda J. Burns; Gregory M. Vercellotti; Xing L. Wang
Infected endothelial cells are found to be resistant to apoptosis possibly mediated by p53 cytoplasmic sequestration. We explored whether the immediate early 84 kDa protein (IE84) of cytomegalovirus (CMV) is responsible for p53 cytoplasmic sequestration. The endothelial cells were transfected with plasmids containing IE1 and 2 coding regions which are known to synthesize IE84 and 72 proteins. Our study found that p53 expression was significantly elevated in endothelial cells transfected with IE1 and 2 plasmids. However, p53 was only found in the nucleus rather than sequestered in the cytoplasm. We have demonstrated that IE84 and 72 are not responsible for p53 dysfunction caused by CMV infection, rather they upregulate p53 function and promote endothelial apoptosis.
Clinical Chemistry | 1998
László Ujhelyi; József Balla; László Muszbek; György Kakuk; John D. Belcher; Harry S. Jacob; Gregory M. Vercellotti; György Balla
Archive | 1985
Gregory M. Vercellotti; B. Sweder van Asbeck; H. S. Jacob
Hematology (Seventh Edition) | 2018
Robert P. Hebbel; Gregory M. Vercellotti
Archive | 2014
Karl A. Nath; Robert P. Hebbel; Gregory M. Vercellotti; John D. Belcher; Chunsheng Chen; Julia Nguyen; Liming Milbauer; Fuad Abdulla; Abdu I. Alayash
Archive | 2013
Gregory M. Vercellotti; John D. Belcher; Mark Young; Chunsheng Chen; Julia Nguyen; Kenneth Burhop; Phuc Tran
Archive | 2013
Robert P. Hebbel; Gregory M. Vercellotti; Zvonimir S. Katusic; Karl A. Nath; Joseph P. Grande; Gianrico Farrugia; Anthony J. Croatt; John D. Belcher
Archive | 2010
John D. Belcher; Paul H. Marker; Jill P. Weber; Robert P. Hebbel; Gregory M. Vercellotti
Archive | 2005
Robert P. Hebbel; Gregory M. Vercellotti; Khalid M. Sonbol; Venkatasubramaniam S. Kalambur; Paul R. Bowlin; D. Belcher; Hemchandra Mahaseth; Thomas E. Welch; Åsa Vilbäck